Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Alimak Group: Fortsatt fokus på lönsam tillväxt

By Jesper HagmanCommunity Manager
Alimak Group

Alimak Group presenterade en Investor Update 20/11 där bolaget gav en uppdatering av koncernens framsteg och pågående aktiviteter som syftar till att uppnå de finansiella mål som tillkännagavs i juni 2023. I denna intervju, med President & VD Ole Kristian Jødahl, behandlar vi Investor Update i stora drag, Alimak Groups strategiarbete samt vad är en investerare ska tänka på när man kikar på Alimak Group.

Alimak Groups Investor Update - Se här

Stay up to date
Company management interviews

Recent videos

Oncopeptides, Audiocast, Investor Conference, 2026
2026-01-16 09:00 Oncopeptides
Duell, Webcast, Q1'26
2026-01-14 09:30 Duell
Dustin Group, Audiocast, Q1'26
2026-01-14 09:00 Dustin Group
Herantis Pharma Plc, Phase 1b biomarker data webcast
2026-01-08 11:00 Herantis Pharma
Investor Day | Nov. 24, 2025
2025-12-23 11:00 United Bankers
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.